General contact

Novartis Pharmaceuticals Canada Inc.
385 Bouchard Blvd
Dorval, Quebec
H9S 1A9

(514) 631-6775
By e-mail : Response times may vary during holidays.
Resident of Canada
Resident of the United States

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Department of Communications
Novartis Pharmaceuticals Canada Inc.
385 Bouchard Blvd.
Dorval, Quebec H9S 1A9

514 633-7873

Pharmaceuticals

Over the past decade, Novartis Pharmaceuticals Canada has introduced 20 new medicines that have had an important impact on patients suffering from a wide variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation and osteoporosis.